Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 05, 2015 09:44 ET | Source: Akari Therapeutics Plc

Akari Therapeutics Announces Upcoming Data Presentations at the 57th American Society of Hematology Annual Meeting

NEW YORK and LONDON, Nov. 05, 2015 (GLOBE NEWSWIRE) -- Akari Therapeutics (NASDAQ:AKTX), an emerging growth, development-stage biopharmaceutical company, announced today that new data on...
September 21, 2015 07:15 ET | Source: Akari Therapeutics Plc

Akari Therapeutics Closes $75 Million Private Placement

NEW YORK and LONDON, Sept. 21, 2015 (GLOBE NEWSWIRE) -- Akari Therapeutics (formerly known as Celsus Therapeutics plc) (NASDAQ:AKTX), an emerging growth, development-stage biopharmaceutical...
September 18, 2015 07:31 ET | Source: Akari Therapeutics Plc

Celsus Therapeutics and Volution Immuno Pharmaceuticals Announce Completion of Acquisition and Formation of Complement C5 Inhibitor Company Akari Therapeutics Plc

NEW YORK and LONDON, Sept. 18, 2015 (GLOBE NEWSWIRE) -- Celsus Therapeutics Plc (NASDAQ:CLTX) and Volution Immuno Pharmaceuticals SA today announced that, following shareholder approval obtained...